CHARLES SCHWAB INVESTMENT MANAGEMENT INC - APPLIED THERAPEUTICS INC ownership

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of APPLIED THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$61,015
+94.5%
24,5040.0%0.00%
Q2 2023$31,365
-62.2%
24,504
-37.1%
0.00%
Q1 2022$83,000
-79.5%
38,968
-13.6%
0.00%
Q4 2021$404,000
-43.9%
45,079
+4.0%
0.00%
Q3 2021$720,000
-20.7%
43,336
-0.7%
0.00%
Q2 2021$908,000
+23.5%
43,653
+11.5%
0.00%
Q1 2021$735,000
-2.1%
39,146
+14.8%
0.00%
Q4 2020$751,000
+5.8%
34,104
-0.3%
0.00%
Q3 2020$710,000
-38.7%
34,195
+6.8%
0.00%
-100.0%
Q2 2020$1,158,000
+72.8%
32,015
+56.3%
0.00%
Q1 2020$670,000
+79.6%
20,486
+50.2%
0.00%
Q4 2019$373,00013,6410.00%
Other shareholders
APPLIED THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 734,980$15,258,00012.50%
Rock Springs Capital Management LP 991,573$20,585,0000.52%
Kore Private Wealth LLC 125,000$2,595,0000.50%
EMERALD MUTUAL FUND ADVISERS TRUST 503,500$10,453,0000.46%
EMERALD ADVISERS, LLC 505,075$10,485,0000.43%
Orbimed Advisors 1,546,687$32,109,0000.40%
DRIEHAUS CAPITAL MANAGEMENT LLC 627,000$13,017,0000.27%
Artal Group S.A. 380,000$7,889,0000.19%
Virtus ETF Advisers LLC 7,571$157,0000.08%
Alkeon Capital Management 738,039$15,322,0000.03%
View complete list of APPLIED THERAPEUTICS INC shareholders